Journal article
Opinion: The optimal use of risk factors to guide palivizumab prophylaxis against severe respiratory syncytial virus infection in moderate-to-late preterm infants
Authors
Paes B; Lanari M; Rodgers-Gray B; Fullarton J; Carbonell-Estrany X
Journal
Frontiers in Pediatrics, Vol. 12, ,
Publisher
Frontiers
DOI
10.3389/fped.2024.1343960
ISSN
2296-2360